Target intelligence / Profile preview

A-kinase anchoring protein 7 (AKAP7)

Target
AKAP7
Molecular classification
Scaffolding protein, A-kinase anchoring protein (AKAP) family, Other
01

Overview

A-kinase anchoring protein 7 (AKAP7) is a member of the AKAP family of scaffolding proteins, characterized by their ability to bind the regulatory subunit (RII) of cAMP-dependent protein kinase A (PKA) and target the enzyme to specific intracellular compartments[1][2][3]. AKAP7 encodes several isoforms (including alpha, beta, and gamma) that localize PKA to distinct subcellular locations, thereby spatially organizing cAMP signaling. The major neuronal isoform (AKAP7α) anchors PKA at presynaptic sites in the hippocampus and other brain regions, where it is essential for anchoring PKA-RIIβ, regulating synaptic plasticity, and affecting learning and memory. The gamma isoform includes a phosphodiesterase-like domain, but its biochemical function is incompletely understood[4]. AKAP7 has emerging roles as a biomarker in certain diseases and is regarded as a key regulator of compartmentalized signal transduction[1][2][3][4].

Other names
A-kinase anchor protein 7 isoform gammaAKAP18AKAP-7 isoform gammaPRKA7 isoform gammaA-kinase anchor protein 7 isoforms alpha and betaAKAP15AKAP-7 isoforms alpha and betaPRKA7 isoforms alpha/betaA-kinase anchor protein 18 kDaProtein kinase A-anchoring protein 7 isoforms alpha/betaProtein kinase A-anchoring protein 7 isoform gammaA kinase (PRKA) anchor protein 7A-kinase anchor protein 9 kDaAKAP 18
02

Mechanism of action

(For AKAP inhibitors: disruption of PKA anchoring to AKAP7, thereby altering subcellular localization of PKA and its downstream signaling)

03

Biological functions

Anchoring cAMP-dependent protein kinase (PKA) to subcellular compartmentsSynaptic plasticityRegulation of ion channel conductanceSignal transduction
04

Disease associations

Neurodegenerative diseaseCognitive dysfunctionOther (potential biomarker in autoimmune disease)
05

Safety considerations

Potential effects on synaptic plasticity and memory with disruption [2]Lack of specific targeted drugs limits known therapeutic safety concerns
06

Biomarkers

Peripheral blood AKAP7 expression (proposed early marker in multiple sclerosis and possibly other diseases) [4]

Beyond the preview

Go deeper on A-kinase anchoring protein 7 (AKAP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-kinase anchoring protein 7 (AKAP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call